These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 33213552)

  • 1. Unrecognized severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare personnel in a low-prevalence area.
    Shah VP; Hainy CM; Swift MD; Breeher LE; Theel ES; Sampathkumar P
    Infect Control Hosp Epidemiol; 2021 Dec; 42(12):1532-1534. PubMed ID: 33213552
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.
    Hunter BR; Dbeibo L; Weaver CS; Beeler C; Saysana M; Zimmerman MK; Weaver L
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1441-1442. PubMed ID: 32741406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare workers in a low prevalence region.
    Godbout EJ; Pryor R; Harmon M; Montpetit A; Greer J; Bachmann LM; Doll M; Stevens MP; Bearman G
    Infect Control Hosp Epidemiol; 2022 Jan; 43(1):120-122. PubMed ID: 33308349
    [No Abstract]   [Full Text] [Related]  

  • 4. Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee.
    Stubblefield WB; Talbot HK; Feldstein LR; Tenforde MW; Ur Rasheed MA; Mills L; Lester SN; Freeman B; Thornburg NJ; Jones ID; Ward MJ; Lindsell CJ; Baughman A; Halasa N; Grijalva CG; Rice TW; Patel MM; Self WH
    Clin Infect Dis; 2021 May; 72(9):1645-1648. PubMed ID: 32628750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark.
    von Huth S; Lillevang ST; Røge BT; Madsen JS; Mogensen CB; Coia JE; Möller S; Justesen US; Johansen IS
    Int J Infect Dis; 2021 Nov; 112():96-102. PubMed ID: 34534698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of Anti-SARS-CoV-2 Antibodies Three Months Post Infection in Healthcare Professionals at an Oncology Hospital in Northern Portugal.
    Silva DF; Silva PD; Torgal A; Braga S; Rocha D; Ochoa C; Oliveira Á; Rocha L; Dias JM; Baldaque I
    Acta Med Port; 2021 Jun; 34(6):484-485. PubMed ID: 34715953
    [No Abstract]   [Full Text] [Related]  

  • 7. High Seroprevalence of SARS-CoV-2 among Healthcare Workers in a North Italy Hospital.
    Airoldi C; Patrucco F; Milano F; Alessi D; Sarro A; Rossi MA; Cena T; Borrè S; Faggiano F
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33804893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam.
    Hasan T; Pham TN; Nguyen TA; Le HTT; Van Le D; Dang TT; Van TD; Pham YN; Nguyen HV; Tran GL; Nguyen VTC; Nguyen TT; Truong VQ; Dao TH; Le CT; Truong NT; Vo HT; Le PT; Nguyen TT; Van Luu V; Nguyen VD; Toelle BG; Marks GB; Fox GJ
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34208212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of SARS-CoV-2 antibodies among North Dakota community pharmacy personnel: A seroprevalence survey.
    Johnson A; Vincent B; Carson P; Skoy E
    J Am Pharm Assoc (2003); 2021; 61(3):e127-e132. PubMed ID: 33568267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
    Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA
    Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees.
    Herzberg J; Vollmer T; Fischer B; Becher H; Becker AK; Sahly H; Honarpisheh H; Guraya SY; Strate T; Knabbe C
    Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and Risk Factors Among Oligo/Asymptomatic Healthcare Workers: Estimating the Impact of Community Transmission.
    Costa SF; Giavina-Bianchi P; Buss L; Mesquita Peres CH; Rafael MM; Dos Santos LGN; Bedin AA; Francisco MCPB; Satakie FM; Jesus Menezes MA; Dal Secco LM; Rodrigues Caron DM; de Oliveira AB; de Faria MFL; de Aurélio Penteado AS; de Souza IOM; de Fatima Pereira G; Pereira R; Matos Porto AP; Sanchez Espinoza EP; Mendes-Correa MC; Dos Santos Lazari C; Kalil J; de Moliterno Perondi MB; de Oliveira Bonfa ESD; Perreira AJ; Sabino E; da Silva Duarte AJ; Segurado AC; Dos Santos VA; Levin AS
    Clin Infect Dis; 2021 Sep; 73(5):e1214-e1218. PubMed ID: 33313659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.
    Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM
    Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG results among healthcare workers in a rural upstate New York hospital system.
    Brunner WM; Hirabayashi L; Krupa NL; Scribani MB; Jenkins P; Clark SD; May JJ; Gadomski AM
    Infect Control Hosp Epidemiol; 2021 Nov; 42(11):1397-1400. PubMed ID: 33100252
    [No Abstract]   [Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.
    Barallat J; Fernández-Rivas G; Quirant-Sánchez B; González V; Doladé M; Martinez-Caceres E; Piña M; Matllo J; Estrada O; Blanco I
    PLoS One; 2020; 15(12):e0244348. PubMed ID: 33370363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut.
    Papasavas P; Olugbile S; Wu U; Robinson K; Roberts AL; O'Sullivan DM; McLaughlin T; Mather JF; Steinberg AC; Orlando R; Kumar A
    J Hosp Infect; 2021 Aug; 114():117-125. PubMed ID: 33930487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].
    Özdemir A; Demir Çuha M; Telli Dizman G; Alp A; Metan G; Şener B
    Mikrobiyol Bul; 2021 Apr; 55(2):223-232. PubMed ID: 33882653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study.
    Ocias LF; Skogstam A; Kjerstadius T; Lundin F; Tevell S
    Infect Dis (Lond); 2021; 53(12):920-929. PubMed ID: 34350813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV).
    Kindgen-Milles D; Brandenburger T; Braun JFW; Cleff C; Moussazadeh K; Mrosewski I; Timm J; Wetzchewald D
    PLoS One; 2021; 16(4):e0248813. PubMed ID: 33831032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.